Fierce Pharma

JUNE 5, 2024

The scope of Bristol Myers Squibb’s $1.5 billion savings drive is beginning to come into focus. | Starting this month, BMS will begin the process of laying off around 863 employees in Lawrenceville, New Jersey, according to a Worker Adjustment and Retraining Notification (WARN) alert from the state. The move forms part of BMS’ campaign to shave off $1.5 billion in costs by the end of 2025, a company spokesperson said over email.

318

318

pharmaphorum

JUNE 5, 2024

An initiative set up by the FDA to accelerate the development of therapies for rare disease in the same way that Operation Warp Speed delivered COVID-19 vaccine has chosen its first pilot programme candidates.

FDA 115

FDA 115

Fierce Pharma

JUNE 5, 2024

After 23 years at Eli Lilly, including the last three as its CFO, Anat Ashkenazi is leaving to take the same role at Google's parent company Alphabet.

304

304

pharmaphorum

JUNE 5, 2024

KRAS inhibitors from Eli Lilly, Genfleet, and InxMed make their case for use in NSCLC at ASCO, as they case down Amgen and Bristol-Myers Squibb's market drugs

Marketing 115

Marketing 115

Advertisement

Fierce Pharma

JUNE 5, 2024

Back in February, Eli Lilly teased “clinically meaningful” results around the ability of its dual GLP-1/GIP med tirzepatide to curb fibrosis in patients with fatty liver disease. | Back in February, Eli Lilly teased “clinically meaningful” results around the ability of its dual GLP-1/GIP med tirzepatide to curb fibrosis in patients with fatty liver disease.

Patients 281

Patients 281

MedCity News

JUNE 5, 2024

Dollar General and DocGo have mutually decided to end their mobile clinic pilot. The decision comes as numerous retailers have struggled in the healthcare sector. The post Another Retailer Bites the Dust. Is There Still Hope for Retailers After Dollar General/DocGo End Pilot? appeared first on MedCity News.

Retail 110

Retail Healthcare Healthcare 110

PharmaVoice

JUNE 5, 2024

Bucking conventional fundraising, FibroBiologics’ CEO Pete O’Heeron explains why the biotech company bet on themselves in the public market.

Marketing 119

Marketing 119

pharmaphorum

JUNE 5, 2024

Gilead Sciences is just a few weeks away from an FDA decision on seladelpar for rare liver disease primary biliary cholangitis (PBC) and will be buoyed by new data pointing to its long-term efficacy and safety.

Safety 107

Safety FDA 107

MedCity News

JUNE 5, 2024

Novo Nordisk’s focus on diabetes and obesity shape its business development work, but the company is also exploring other areas. Top Novo Nordisk M&A executive John McDonald discussed his company’s strategy during a session at the BIO conference in San Diego. The post At BIO, Novo Nordisk’s Top Dealmaker Talks M&A Strategy and What’s Next After GLP-1s appeared first on MedCity News.

Biopharma 106

Biopharma Pharma 106

pharmaphorum

JUNE 5, 2024

NHS hospitals in London have declared a critical incident caused by a ransomware attack on a pathology services provider, leading to cancelled procedures and patients having to be transferred to different care providers. The attack on Synnovis has had an impact on patient care at Guy’s and St Thomas’ and King’s College Hospital NHS Foundation Trusts, as well as GP services in southeast London, according to an NHS England statement.

Patients 101

Patients Leads 101

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

JUNE 5, 2024

More than 100 skilled consultants to self-insured employers shared their perspectives on the changing dynamics in healthcare benefits in MedCity News’ second annual 2024 Benefit Consultant Sentiment Index (The Index): Benefit Consultants’ Perspective on Shifting Employer Healthcare Landscape. The report functions as an insider’s guide to understanding how healthcare trends are shaping employer benefit decisions from the perspective of consultants.

Consulting 102

Consulting Insurance Healthcare Healthcare 102

Copyright Clearance Center

JUNE 5, 2024

June 5, 2024 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, announced its collaboration with key industry stakeholders to launch the Leiden Institute for FAIR and Equitable Science (LIFES). In recognition of the challenges that exist with data reuse within the global research community, LIFES is a joint effort by an international public-private partnership of eleven academic and private organizations to build a wide and diverse network

Ethics 98

Ethics Education Networking Leads 98

MedCity News

JUNE 5, 2024

As the volume of healthcare data accelerates, health system leaders must take critical steps to elevate the quality, completeness and accessibility of data they capture, manage and aggregate. The post Healthcare’s Data Problem: So Much Data, yet So Little Data Fidelity appeared first on MedCity News.

Healthcare 99

Healthcare Healthcare Management 99

European Pharmaceutical Review

JUNE 5, 2024

New clinical data from a Phase II trial for rectal cancer has revealed a 100 percent clinical complete response rate following first-line therapy with Jemperli (dostarlimab-gxly). These findings from GSK reflect outcomes from 42 patients with mismatch repair deficient (dMMR) locally advanced rectal cancer who finished the treatment. The trial investigated the therapy as an alternative to surgery.

Safety 98

Safety Patients Manufacturing Medicine 98

Advertisement

Distribution

MedCity News

JUNE 5, 2024

We’re in for a bumpy ride near term, but value-based specialty care (VBSC) is coming and – if done right – has the potential to transform how we care for millions of patients. The post Making the Transition to Value-Based Specialty Care appeared first on MedCity News.

Patients 98

Patients 98

European Pharmaceutical Review

JUNE 5, 2024

A report by the Business Research Company predicts that the small molecule injectable drugs market will value $355.14 billion in 2028. As such, the compound annual growth rate (CAGR) is expected to be 12.8 percent up to this period. Factors that are anticipated to facilitate this growth of the market include personalised treatments , supply chain optimisation and use of real-world evidence, according to the research.

Marketing 97

Marketing Pharmaceutical Patients 97

pharmaphorum

JUNE 5, 2024

PHTI's latest report finds that digital therapies for musculoskeletal conditions like low back pain can deliver clinically meaningful benefits

106

106

PharmaTech

JUNE 5, 2024

Lee Cronin, founder and CEO of Chemify, discusses the combination of digital chemistry, robotics, and AI in the drug discovery space.

110

110

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

Pharmaceutical Commerce

JUNE 5, 2024

The development and manufacturing plant will be constructed in Texas, and is expected to become operational by Q1 2025.

Manufacturing 100

Manufacturing 100

Pharmaceutical Technology

JUNE 5, 2024

The US FDA has granted orphan drug designation to Be Biopharma’s (Be Bio) BE-101 for the treatment of haemophilia B.

FDA 98

FDA 98

MedCity News

JUNE 5, 2024

CoraVie Medical, a startup developing an implantable continuous blood pressure monitor, recently won the medical devices track of MedCity News’ INVEST Pitch Perfect contest. The pre-revenue company’s remote management solution monitors for the early detection of dangerous blood pressure levels to prevent crises that could lead to heart attack, stroke, kidney failure or death.

Medical 76

Medical Management Leads 76

Pharmaceutical Commerce

JUNE 5, 2024

The courts reversed certain key guidance documents issued by the Health Resources and Services Administration for the 340B Program, which raises uncertainty.

81

81

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

PharmaTimes

JUNE 5, 2024

Extended phase 2 study highlights macrophage cell therapy’s efficacy

97

97

Pharmaceutical Technology

JUNE 5, 2024

5 June marks World Environment Day, an annual celebration that encourages global awareness and action to protect the environment.

72

72

PharmaTimes

JUNE 5, 2024

Phase 3 research suggests a significant leap forward in myeloma management

Management 92

Management 92

Pharmaceutical Commerce

JUNE 5, 2024

The latest news for pharma industry insiders.

Pharma 105

Pharma Patients 105

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Rep-Lite

JUNE 5, 2024

In the highly competitive medical sales industry, finding top-tier talent is a constant challenge. The power of networking can be used to foster strong connections, and it is at this point medical sales recruiters gain a significant edge in attracting and securing the best candidates. At Rep-Lite, we understand the importance of building a robust network.

Medical sales 52

Medical sales Recruitment Networking Sales 52

PharmaTech

JUNE 5, 2024

Pharmaceutical Technology® spoke with Parviz Shamlou, senior vice-president of Science and Technology, Abzena, about the impact of the Biosecure Act on the bio/pharmaceutical industry, as well as the progress of continuous manufacturing in biopharma.

Biopharma 52

Biopharma Pharma Manufacturing Pharmaceutical 52

Evolve Your Success

JUNE 5, 2024

Unlock the secrets to thriving in the specialized field of wound care diagnostics with insights from Zac Dotinga, Assistant Regional Manager at Advanced Pathology Solutions. This episode promises to illuminate the intricacies of working with podiatry offices and wound care centers, sharing how pathology services, like confirming fungal infections, play a pivotal role.

Medical sales 52

Medical sales Medical Sales Interpersonal Skills 52

pharmaphorum

JUNE 5, 2024

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Rob Pears, VP and head of automotive, manufacturing, and life sciences at Capgemini, which partners with companies to transform and manage their business by harnessing the power of technology.

Manufacturing 52

Manufacturing Management 52

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization